MoneyWorks4Me

Medicamen Biotech informs about press release

31 May 2024 Evaluate
Pursuant to regulation 30 & 47 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015 (the Regulations), Medicamen Biotech has informed that it enclosed newspaper cutting with regard to the publication of extract of Audited Financial Results of the Company for the quarter and year ended on March 31, 2024 approved by the Board of Directors at their Meeting held on 29.05.2024. The copy of the results published in the Financial Express and Jansatta dated May 30, 2024 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..